A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
about
F-box protein FBXL19-mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammationInterleukin-33 in allergyElevated levels of soluble ST2 protein in dengue virus infected patientsTriad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptorsParacrine IL-33 stimulation enhances lipopolysaccharide-mediated macrophage activationNegative regulation of the RIG-I signaling by the ubiquitin ligase RNF125Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammationIL-33 reduces the development of atherosclerosisSoluble ST2 levels are associated with bleeding in patients with severe Leptospirosis.Interleukin-33 contributes to both M1 and M2 chemokine marker expression in human macrophages.Soluble ST2, a modulator of the inflammatory response, in preterm and term laborThe effect of ST2 gene product on anchorage-independent growth of a glioblastoma cell line, T98G.Daily exposure to dust alters innate immunityIL-33 is a crucial amplifier of innate rather than acquired immunitySoluble ST2 in the fetal inflammatory response syndrome: in vivo evidence of activation of the anti-inflammatory limb of the immune responseST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance.Deletion of IL-33R (ST2) abrogates resistance to EAE in BALB/C mice by enhancing polarization of APC to inflammatory phenotypeThe IL-33/ST2 pathway: therapeutic target and novel biomarker.Streptococcus cristatus attenuates Fusobacterium nucleatum-induced cytokine expression by influencing pathways converging on nuclear factor-κB.Signaling through the T1/ST2 molecule is not necessary for Th2 differentiation but is important for the regulation of type 1 responses in nonhealing Leishmania major infectionTargeting ST2L potentiates CpG-mediated therapeutic effects in a chronic fungal asthma model.Focal adhesion kinase-mediated activation of glycogen synthase kinase 3β regulates IL-33 receptor internalization and IL-33 signaling.Soluble ST2 plasma concentrations predict mortality in HBV-related acute-on-chronic liver failureToll/interleukin-1 receptor member ST2 exhibits higher soluble levels in type 2 diabetes, especially when accompanied with left ventricular diastolic dysfunction.Limiting inflammatory responses during activation of innate immunity.Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling.A comprehensive map of the toll-like receptor signaling network.IL-33 mediates antigen-induced cutaneous and articular hypernociception in miceMarkers of increased atherosclerotic risk in patients with chronic kidney disease: a preliminary study.Negative regulatory approaches to the attenuation of Toll-like receptor signaling.TLR2 is expressed on activated T cells as a costimulatory receptorThe negative regulation of Toll-like receptor and associated pathways.Glia maturation factor-γ negatively modulates TLR4 signaling by facilitating TLR4 endocytic trafficking in macrophages.Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load.ST2 deletion enhances innate and acquired immunity to murine mammary carcinomaImpaired bacterial clearance in type 3 deiodinase-deficient mice infected with Streptococcus pneumoniae.Promyelocytic leukemia zinc finger protein regulates interferon-mediated innate immunityIL-33-activated dendritic cells induce an atypical TH2-type response.Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.The biological and clinical importance of the 'new generation' cytokines in rheumatic diseases
P2860
Q24337221-F3AFF8E6-EDDE-4F97-AEDB-DC74EBB99296Q27006244-3F23B742-EF58-49C6-A523-8C4ACD7BD06EQ27485633-B0D3B284-3A9F-42EF-AA25-1763569FBF3EQ28258400-8F750864-11E0-4D94-BCC8-6D255729DF83Q28505577-5124AA55-0C9C-4211-8ECA-F4049DE15A86Q28507841-D3A90875-574D-4E98-81E3-F797AD61C891Q28586791-ECCA8549-1233-4596-8EFB-A11B13B93D5FQ28594104-74D0CD8E-CC51-4464-BD2C-F3FC009FA715Q33458347-B2A6E50A-5F8B-4EB4-81B2-736F0EC3B92EQ33722773-5B4388C4-F098-4209-8CE8-EFE6967126DFQ34164039-54711523-D2F4-45A7-BDCD-D01DABC6857CQ34166051-4C29ECFD-2202-4C39-B66D-72711DF9649FQ34166427-D9411FC9-2DC2-4450-99F0-5287ACCF700BQ34276672-007E93B9-D1C5-454A-ADD6-7F7AD7F12207Q34281893-9DB491F7-2941-42D5-8B12-AB4D3C902F07Q34303629-3EFEF4BD-F785-446C-BFFF-9D3E71AD9BC0Q34428400-66DEAAC5-56B7-4842-A24E-BA8D84C9242DQ34776884-C28C12C0-028B-4E8D-9A93-0435E907C872Q34802649-5F759D47-0321-4871-B261-934B42551A7FQ34852307-0CB5CBFB-71A8-45DB-8A5F-AC5509ABBDF3Q35070119-950ECA85-4FC7-4F38-97BD-FE2FCC3D4C7FQ35189260-66C71A39-457A-447D-B73D-FBB0C8D07F99Q35373003-657CF87D-5705-409A-910D-7DDEDECE738EQ35588992-1D24D058-2896-46A7-9D63-B4507BB3C94BQ36348742-2EDD7F57-9692-48D5-9491-DBB4B63FFA83Q36377195-18938B65-45DE-4726-B062-CD364A943528Q36494115-D244F9EF-C21B-4A6B-B092-16411E402BBCQ36497523-EE4C1C25-557A-4FCD-8D70-49F724340839Q36538088-F2D2759F-C170-45D5-BCFC-16FA38B544F9Q36645845-4F499D6A-9784-4947-8E75-EEEA714CE37EQ36853515-619280BE-37D0-410C-AEF8-457D21E87377Q36875508-28C5B074-8BD2-4745-B1B4-4DA323FAEF90Q36920318-8BC3DB43-9307-465E-9E56-B44E41DFFBCFQ37087572-F703E22C-6770-4A9E-8AF4-B233D9AC3A8DQ37101727-9FBB0D6E-D50C-4ED0-B5F7-C40B8CBFDBCFQ37136923-F850FAB4-A673-426F-8219-F3B803970A1FQ37263050-E172F53B-AC13-490E-9648-E0FA56E59C3BQ37265087-477CAA82-BC7F-4583-BAF3-6867A86AF051Q37367885-3C50A37F-614F-4A3C-92ED-E58B7FDB477AQ37516563-78ECF6C4-2D31-48A3-B2D5-2835F0BE0454
P2860
A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor 4 expression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@ast
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@en
type
label
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@ast
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@en
prefLabel
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@ast
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@en
P2093
P1476
A novel pathway regulating lip ...... ll-like receptor 4 expression.
@en
P2093
C C Campbell
V Trajkovic
P304
P356
10.4049/JIMMUNOL.166.11.6633
P407
P577
2001-06-01T00:00:00Z